Tom Allen has sold SYNH and made no open-market buys since Sep 2020

Allen Tom (commonly listed as Tom Allen) is a director of Syneos Health, Inc., a global biopharmaceutical solutions organization, and is recorded as a corporate insider in connection with trades in Syneos Health (SYNH).( As a member of the company’s board of directors, he participates in overseeing corporate governance and strategic direction for the business.( Syneos Health provides clinical and commercial services to pharmaceutical and biotechnology clients, and its board plays a key role in guiding the firm’s long‑term growth and risk management.(

Publicly available insider-trading and governance disclosures identify Tom Allen as a director but provide limited additional personal detail beyond his board service and status as a reporting insider at Syneos Health.( Based on these filings, he is categorized as an individual corporate insider rather than a separate corporate entity.(

Written by Perplexity from public sources.